Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Can aggressive behavior in humans be modified by beta blockers?

J Volavka1

  • 1Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York.

Postgraduate Medicine
|February 29, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hostility in schizophrenia: An integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies.

European psychiatry : the journal of the Association of European Psychiatrists·2015
Same author

ITAREPS relapse prevention in schizophrenia.

International journal of clinical practice·2009
Same author

Heterogeneity of violence in schizophrenia and implications for long-term treatment.

International journal of clinical practice·2008
Same author

Update on the biological treatment of aggression.

Actas espanolas de psiquiatria·2006
Same author

Antiaggressive effect of quetiapine in a patient with schizoaffective disorder.

The Journal of clinical psychiatry·2002
Same author

Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.

Psychiatric services (Washington, D.C.)·2001

Beta blockers may help control aggression in patients with brain disorders. Studies show propranolol reduced aggressive behavior in 86% of patients, suggesting a potential treatment, though more research is needed.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Persistent aggressive behavior is observed in various brain disorders.
  • A hyperadrenergic state is a potential neurochemical basis for aggression.
  • Beta blockers are hypothesized to control aggression, possibly via peripheral mechanisms.

Purpose of the Study:

  • To review the efficacy of beta blockers in managing aggressive behavior associated with organic brain disorders.
  • To explore the potential site of action for beta blockers' antiaggressive effects.

Main Methods:

  • Review of several studies involving aggressive patients with organic brain disorders treated with propranolol.
  • Analysis of patient responses to beta blocker treatment, including those unresponsive to previous therapies.

Related Experiment Videos

Main Results:

  • Propranolol reduced aggressive behavior in 75 (86%) of 87 patients.
  • Efficacy of nadolol, which poorly crosses the blood-brain barrier, suggests peripheral action.
  • Most studies were retrospective and lacked placebo controls, except for one small study.

Conclusions:

  • Beta blockers, particularly propranolol, show promise in reducing aggression in patients with organic brain disorders.
  • Further research with prospective, double-blind, placebo-controlled designs and larger sample sizes is warranted.
  • Development of improved aggression measurement tools is needed for future studies.